Identification of the high-virulence clone of group B streptococci by using a probe containing a putative aldolase gene

Current Microbiology

Volumn 47, Issue 4, 2003, Pages 319-322

  Palacios, Gerardo C ^a   Timmons, Brenda C ^b   Eskew, Elizabeth K ^b   Solórzano, Fortino ^a   Mattingly, Stephen J ^b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSE BISPHOSPHATE ALDOLASE; GENOMIC DNA;

ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; CLONE; CULTURE MEDIUM; DNA HYBRIDIZATION; MEXICO; NONHUMAN; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE;

BACTERIAL TYPING TECHNIQUES; BLOTTING, SOUTHERN; DNA PROBES; DNA, BACTERIAL; ENZYME STABILITY; FRUCTOSE-BISPHOSPHATE ALDOLASE; GENOTYPE; HUMANS; NUCLEIC ACID HYBRIDIZATION; PHENOTYPE; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE; TEMPERATURE; VIRULENCE;

ANIMALIA; BACTERIA (MICROORGANISMS); POSIBACTERIA; STREPTOCOCCUS; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 0042362197     PISSN: 03438651     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00284-002-3957-5     Document Type: Article

References (29)

1. Ausubel FM, Brent R, Kingston RE, Moore DD, Smith JA, Seidman JG, Struhl K (1987) Current protocols in molecular biology. New York: Wiley Intersciences
2. Baker CJ, Edwards MS (1995) Group B streptococcal infections. In: Remington JS, Klein JO (eds) Infectious diseases of the fetus and newborn infant, 4th edn. Philadelphia: W.B. Saunders, pp 980-1054
3. Blumberg HM, Stephens DS, Licitra C, Pigott N, Facklam R, Swaminathan B, Wachsmuth IK (1992) Molecular epidemiology of group B streptococcal infections: use of restriction endonuclease analysis of chromosomal DNA and DNA restriction fragment length polymorphisms of ribosomal RNA genes (ribotyping). J Infect Dis 166:574-579
4. Colman G (1988) Typing of Streptococcus agalactiae (Lancefield group B). Eur J Clin Microbiol Infect Dis 7:226-231
5. Doran TI, Straus DC, Mattingly SJ (1981) Factors influencing release of type III antigens by group B streptococci. Infect Immun 31:615-623
6. Ellis S, Kotiw M, Garland SM (1996) Restriction endonuclease analysis of group B streptococcal isolates from two distinct geographical regions. J Hosp Infect 33:279-287
7. Facklam RR, Washington JA II (1991) Streptococcus and related catalase-negative Gram-positive cocci. In: Balows A, Hausler WJ Jr, Herrmann KL, Isenberg HD, Shadomy HJ (eds) Manual of clinical microbiology, 5th edn. Washington, DC: American Society for Microbiology, pp 238-257
8. Hauge M, Jespersgaard C, Poulsen K, Kilian M (1996) Population structure of Streptococcus agalactiae reveals an association between specific evolutionary lineages and putative virulence factors but not disease. Infect Immun 64:919-925
9. Helmig R, Uldbjerg N, Boris J, Kilian M (1993) Clonal analysis of Streptococcus agalactiae isolated from infants with neonatal sepsis or meningitis and their mothers and from healthy pregnant women. J Infect Dis 168:904-909
10. Mattingly SJ, Eskew EK (1993) Temperature sensitivity of fructose-1,6-biphosphate aldolase accounts for the inability of the high-virulence clone of Streptococcus agalactiae to grow at 40°C. Curr Microbiol 26:147-150
11. Mattingly SJ, Maurer JJ, Eskew EK, Cox F (1990) Identification of a high-virulence clone of serotype III Streptococcus agalactiae by growth characteristics at 40°C. J Clin Microbiol 28:1676-1677
12. Milligan TW, Baker CJ, Straus DC, Mattingly SJ (1978) Association of elevated levels of extracellular neuraminidase with clinical isolates of type III group B streptococci. Infect Immun 21:738-746
13. Musser JM, Mattingly SJ, Quentin R, Goudeau A, Selander RK (1989) Identification of a high-virulence clone of type III Streptococcus agalactiae (group B Streptococcus) causing invasive neonatal disease. Proc Natl Acad Sci USA 86:4731-4735
14. Nealon TJ, Mattingly SJ (1983) Association of elevated levels of cellular lipoteichoic acid of group B streptococci with human neonatal disease. Infect Immun 39:1243-1251
15. Palacios GC, Eskew EK, Solorzano F, Mattingly SJ (1997) Decreased capacity for type-specific antigen synthesis accounts for high prevalence of nontypeable strains of group B streptococci in Mexico. J Clin Microbiol 35:2923-2926
16. Palacios GC, Eskew EK, Solorzano F, Mattingly SJ (1999) Identification of the high-virulence clone of group B streptococci in Mexican isolates by growth characteristics at 40°C. Curr Microbiol 38:126-131
17. Palacios-Saucedo G, Caltenco-Serrano R, Torres-López J, Tapia-Conyer R, Muñoz-Hernández O, Solórzano-Santos F (2002) Exposicíón a estreptococo del grupo B en mujeres mexicanas en edad reproductiva. Salud Publica Mex 44:50-56
18. Quentin R, Huet H, Wang F, Geslin P, Goudeau A, Selander RK (1995) Characterization of Streptococcus agalactiae by multilocus enzyme genotype and serotype: identification of multiple virulent clone families that cause invasive neonatal disease. J Clin Microbiol 33:2576-2581
19. Rolland K, Marois C, Siquier V, Cattier B, Quentin R (1999) Genetic features of Streptococcus agalactiae strains causing severe neonatal infections, as revealed by pulsed-field gel electrophoresis and hylB gene analysis. J Clin Microbiol 37:1892-1898
20. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual, 2nd edn. New York: Cold Spring Harbor Laboratory Press
21. Schuchat A, Wenger JD (1994) Epidemiology of group B streptococcal disease: risk factors, prevention strategy, and vaccine development. Epidemiol Rev 16:374-402
22. Singer M, Rossmiessl P, Cali BM, Liebke H, Gross CA (1991) The Escherichia coli ts8 mutation is an allele of fda, the gene encoding fructose-1,6-diphosphate aldolase. J Bacteriol 173:6242-6248
23. Solorzano-Santos F, Echaniz-Aviles G, Conde-Gonzalez CJ, Calderon-Jaimes E, Arredondo-Garcia JL, Beltran-Zuniga M (1989) Cervicovaginal infection with group B streptococci among pregnant Mexican women. J Infect Dis 159:1003-1004
24. Solorzano-Santos F, Diaz-Ramos RD, Arredondo-Garcia JL (1990) Diseases caused by group B Streptococcus in Mexico. Pediatr Infect Dis J 9:66
25. Su CH, Merlie JP, Goldfine H (1975) Rapid cessation of phospholipid synthesis in fructose-1,6-diphosphate aldolase mutants of Escherichia coli. J Bacteriol 122:565-569
26. Takahashi S, Adderson EE, Nagano Y, Nagano N, Briesacher MR, Bohnsack JF (1998) Identification of a highly encapsulated, genetically related group of invasive type III group B streptococci. J Infect Dis 177:1116-1119
27. Timmons BC, Lee LN, Eskew EK, LeBlanc DJ, Mattingly SJ (1994) Molecular analysis of the high-virulence clone of group B Streptococcus. Abstracts of the Annual Meeting of the American Society for Microbiology 1994:67
28. Yeung MK, Mattingly SJ (1984) Biosynthetic capacity for type-specific antigen synthesis determines the virulence of serotype III strains of group B streptococci. Infect Immun 44:217-221
29. Zangwill KM, Schuchat A, Wenger JD (1992) Group B streptococcal disease in the United States, 1990: report from a multistate active surveillance system. Morbid Mortal Weekly Rep 41(SS-6): 25-32